Abstract
Survivors of childhood acute lymphoblastic leukemia (ALL) are at risk of long-term late effects. Therefore, systematic screenings of the late complications are essential. The objective of this study was to determine the prevalence of late effects of Thai children and adolescents after completion of ALL therapy. We performed a cross-sectional study for evaluation of the late effects in ALL survivors who came for follow-up at 10 pediatric oncology centers in Thailand. We evaluated the treatment-related late complications of children and adolescents who had finished ALL treatment for at least 2 years. Demographic data, treatment modalities, and late effects were recorded and analyzed. There were 258 survivors with a median age of 12.2 years (range 3.6–23.3 years). The median follow-up time was 7.2 years (range 2–17.5 years). Forty-seven percent (122 cases) suffered from at least one late effect. Overweight/obesity was the most common late effect. Radiation of central nervous system was a significant risk factor for overweight/obesity (OR 1.97, 95% CI 1.02–3.81) and educational problems (OR 4.3, 95% CI 1.32–14.02). Our data have demonstrated a significant prevalence of late effects after childhood ALL therapy. A long-term follow-up program for survivors of childhood cancer is therefore needed in our country.
Similar content being viewed by others
References
Pui CH. Childhood leukemias. N Engl J Med. 1995;332:1618–30.
Haddy TB, Mosher RB, Reaman GH. Late effects in long-term survivors after treatment for childhood acute leukemia. Clin Pediatr. 2009;48:601–8.
von der Weid N. Late effects in long-term survivors of ALL in childhood: experiences from the SPOG late effects study. Swiss Med Wkly. 2001;131:180–7.
Bhatia S. Late effects among survivors of leukemia during childhood and adolescence. Blood Cell Mol Dis. 2003;31:84–92.
Mody R, Li S, Dover DC, et al. Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood. 2008;111:5515–23.
Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.
Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundation for providing risk-based health care for survivors. CA Cancer J Clin. 2004;54:208–36.
Wiangnon S, Kamsa-ard S, Jetsrisuparb A, et al. Childhood cancer in Thailand: 1995–1997. Asian Pacific J Cancer Prev. 2003;4:337–43.
Laosombat V, Wongchanchailert M, Sattayasevana B, Wiriyasateinkul A, Watana-Arepornchai S. The treatment of children with acute lymphoblastic leukemia in Thailand. Med Pediatr Oncol. 2002;38:266–8.
Pui CH, Sandlund JT, Pei D, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children’s Research Hospital. Blood. 2004;104:2690–6.
Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: The Children’s Oncology Group Long-Term Follow-Up Guidelines from the Children’s Oncology Group late effects committee and nursing discipline. J Clin Oncol. 2004;22:4979–90.
Aekplakorn W, Mo-suwan L. Prevalence of obesity in Thailand. Obes Rev. 2009;10:589–92.
Rogers PC, Meacham LR, Oeffinger KC, Henry DW, Lange BJ. Obesity in pediatric oncology. Pediatr Blood Cancer. 2005;45:881–91.
Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Survivor Study. J Clin Oncol. 2003;21:1359–65.
Sklar CA, Mertens AC, Walter A, et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol. 2000;35:91–5.
Razzouk BI, Rose SR, Hongeng S, et al. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J Clin Oncol. 2007;25:1183–9.
Asner S, Ammann RA, Ozsahin H, Beck-Popovic M, von der Weid NX. Obesity in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51:118–22.
Jaruratanasirikul S, Owasith K, Wongchanchailert M, Laosombat V, Sriplung H. Growth patterns and final height of survivors of childhood leukemia. J Pediatr Endocrinol Metab. 2004;17:719–26.
Sklar C, Mertens A, Walter A, et al. Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr. 1993;123:59–64.
Kurt BA, Armstrong GT, Cash DK, et al. Primary care management of the childhood cancer survivor. J Pediatr. 2008;152:458–66.
Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory. Med Pediatr Oncol. 2002;38:320–8.
Hudson MM. Survivors of childhood cancer: coming of age. Hematol Oncol Clin N Am. 2008;22:211–31.
Oeffinger KC, Nathan PC, Kremer LCM. Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Pediatr Clin N Am. 2008;55:251–73.
Pui CH, Cheng C, Leung W, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med. 2003;349:640–9.
Acknowledgments
This study was supported by National Research Council of Thailand, Clinical Research Collaboration Network (CRCN), and the Thai Society of Hematology. We thank Director of CRCN, Professor Piyatat Tatsanavivat. We would like to thank Ms Sommaphun Tabjareon who served as a project coordinator and analyzed the data. We also wish to thank Professor Amnuay Thithapandha for his help with English editing of this manuscript.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Pakakasama, S., Veerakul, G., Sosothikul, D. et al. Late effects in survivors of childhood acute lymphoblastic leukemia: a study from Thai Pediatric Oncology Group. Int J Hematol 91, 850–854 (2010). https://doi.org/10.1007/s12185-010-0594-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-010-0594-9